Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vagif, Atduev"'
Autor:
Vladimir Vaks, Elena Domracheva, Maria Chernyaeva, Vladimir Anfertev, Anna Maslennikova, Vagif Atduev, Kurban Atduev, Mikhail Rodionov
Publikováno v:
Applied Sciences, Vol 14, Iss 5, p 1955 (2024)
The results of using nonstationary high-resolution THz spectroscopy for detecting a characteristic set of metabolites of thermal decomposition products of urine from prostate cancer patients, aimed at identifying specific markers, are presented. Stud
Externí odkaz:
https://doaj.org/article/6736b9ad39854bf590d9f9a7d207d2a2
Autor:
Renato D. Lopes, Celestia S. Higano, Susan F. Slovin, Adam J. Nelson, Robert Bigelow, Per S. Sørensen, Chiara Melloni, Shaun G. Goodman, Christopher P. Evans, Jan Nilsson, Deepak L. Bhatt, Noel W. Clarke, Tine K. Olesen, Belinda T. Doyle-Olsen, Henriette Kristensen, Lauren Arney, Matthew T. Roe, John H. Alexander, Mirjam Mol-Arts, Samreen Mansor-Lefebvre, Konstantin Zubovskiy, Allan Blemings, Klaus Dugi, Gerald Bloomfield, Chris Kontos, Adam DeVore, Dedrick Jordan, Bradley Kolls, Robin Matthews, Rajendra Mehta, Thomas J. Povsic, Michael Morse, Kenneth W. Mahaffey, Susan Halabi, Darryl Leong, Laurence Klotz, Neil Fleshner, Godfrey Jansz, Jonathan Giddens, Russell Egerdie, Joseph Chin, Joseph Zadra, Richard Casey, Jean Simard, Tamim Niazi, André-Guy Martin, Marek Babjuk, Jaroslav Hajek, Jiri Klecka, Jiri Kubes, Jan Schraml, Jitka Jakesova, Jaroslav Vanasek, Bohuslav Melichar, Heikki Seikkula, Manouar Samir Abdiche, Marc Colombel, Philippe Debourdeau, Gregoire Robert, Arnauld Villers, Guillaume Ploussard, Benjamin Pradere, Franck Bruyere, Jean-Luc Descotes, Idir Ouzaid, Alexander Winter, Herbert Hanitzsch, Herbert Sperling, Ralf Eckert, Peter Hammerer, Elke Stagge, Florian Seseke, Silvio Szymula, Aristotelis Bamias, Anastasios Thanos, Konstantinos Hatzimouratidis, Charalambos Mamoulakis, Haralabos Kalofonos, Elzbieta Oszukowska, Katarzyna Madziarska, Jacek Fijuth, Mateusz Obarzanowski, Boris Alekseev, Vagif Atduev, Dmitri Pushkar, Evgeniy Veliev, Alexander Zyryanov, Sergey Petrov, Evgeny Kopyltsov, Vadim Kozlov, Ladislav Macko, Jozef Dubravicky, Richard Polak, Obaidullah Mir, Marek Vargovcak, Ivan Mincik, Jan Kliment, Frederico Goncalves, Juraj Mikulas, Roman Sokol, Michal Korcek, Jozef Marko, Viktor Kovacik, Igor Milichovsky, Pavol Dubinsky, John Lazarus, Sanjay Dixit, Euan Green, Rajaguru Srinivasan, Danish Mazhar, Yeung Ng, Naveed Sarwar, Craig Herman, Frederick Snoy, Robert Given, Ronald Suh, David Lipsitz, James Bailen, Lawrence Gervasi, Idalia Acosta, Laurence Belkoff, Ning Wu, Jeffrey Frankel, Lawrence Karsh, Bryant Poole, David Lieber, Jason Engel, Mohamed Bidair, Steven Rosenberg, Paul Sieber, Adam Perzin, Susan Kalota, Amar Singh, Ralph Henderson, Jeffrey Wayne, Moben Mirza, Richard D’Anna, Fredrick Wolk, Osvaldo Padron, Kathryn Bylow, Jonathan Rubenstein, Benjamin Gartrell, Michael Schwartz, Kalpesh Patel, Ajit Maniam, Thomas Keane, Michael Goodman, Charles Bane, Michael Chung, Stephen Savage, Edward Uchio, Son Nguyen, William Aronson, Rakesh Khanna, Carlton Barnswell
Publikováno v:
Circulation. 144(16)
Background: The relative cardiovascular safety of gonadotropin-releasing hormone (GnRH) antagonists compared with GnRH agonists in men with prostate cancer and known atherosclerotic cardiovascular disease remains controversial. Methods: In this inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd9271ccb4eb75e7486635b0056df019
https://pubmed.ncbi.nlm.nih.gov/35312383
https://pubmed.ncbi.nlm.nih.gov/35312383
Autor:
Gustavo Vasconcelos Alves, Marie-Laurence Harle-Yge, Justin Hanover, Nobuaki Matsubara, Jorge D. Gallo, Matthew Wongchenko, David Olmos, Boris Alekseev, Sergio Bracarda, Daniil Stroyakovskiy, Michael Borre, Kim N. Chi, Christopher Sweeney, Evangelos Bournakis, Josep Garcia, Gary L. Buchschacher, Luis Corrales, Rustem Gafanov, Vagif Atduev, Shahneen Sandhu, Johann S. de Bono, Francis Parnis, Javier Puente, Christophe Massard, Cora N. Sternberg, Geng Chen
Publikováno v:
Sweeney, C, Bracarda, S, Sternberg, C N, Chi, K N, Olmos, D, Sandhu, S, Massard, C, Matsubara, N, Alekseev, B, Parnis, F, Atduev, V, Buchschacher, G L, Gafanov, R, Corrales, L, Borre, M, Stroyakovskiy, D, Alves, G V, Bournakis, E, Puente, J, Harle-Yge, M L, Gallo, J, Chen, G, Hanover, J, Wongchenko, M J, Garcia, J & de Bono, J S 2021, ' Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150) : a multicentre, randomised, double-blind, phase 3 trial ', The Lancet, vol. 398, no. 10295, pp. 131-142 . https://doi.org/10.1016/S0140-6736(21)00580-8
Background: The PI3K/AKT and androgen-receptor pathways are dysregulated in metastatic castration-resistant prostate cancers (mCRPCs); tumours with functional PTEN-loss status have hyperactivated AKT signalling. Dual pathway inhibition with AKT inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ed49d978b85e5e5b25c9832cd16319e
https://pubmed.ncbi.nlm.nih.gov/34246347
https://pubmed.ncbi.nlm.nih.gov/34246347
Autor:
Boris Alexeev, Liudmila Lyubchenko, Marat Gordiev, Maxim Filipenko, Yulia Anzhiganova, Alexander Sultanbaev, Alexander Bystrov, Alexander Orlov, Galina Gopp, Evgeny Kopyltsov, Alexander Lykov, Vagif Atduev, Galina Alekseeva, Ovsep Mailyan, Vladislav Semenov, Olga Vedrova, Alexander Perevoschikov, Sergei Andreev, Logacheva Evgenia
Publikováno v:
Journal of Clinical Oncology. 40:169-169
169 Background: The HRRm detection is used to prescribe PARP inhibitors in mCRPC patients. The frequency of HRR alterations has been investigated in several clinical studies, but the prevalence of HRRm in real clinical practice remains unclear. We co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b66b206f0a4900abfbcbe5148f185c17
https://doi.org/10.1200/jco.2022.40.6_suppl.169
https://doi.org/10.1200/jco.2022.40.6_suppl.169
Autor:
Yohann Loriot, Petros Grivas, Ronald De Wit, Arjun Vasant Balar, Arlene O. Siefker-Radtke, Jakub Zolnierek, Tibor Csoszi, Sang Joon Shin, Se Hoon Park, Vagif Atduev, Mahmut Gumus, Yu-Li Su, Saziye Burcak Karaca, Hernan Cutuli, Mehmet Nahit Sendur, Calvin Jia, Karen O'Hara, Sonia Franco, Nobuaki Matsubara
Publikováno v:
Journal of Clinical Oncology. 40:432-432
[No Abstract Available]
Merck Sharp Dohme Corp.; Eisai Inc., Woodcliff Lake, NJ, USA
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and Eisai Inc., Woodcliff Lake, NJ, USA.
Merck Sharp Dohme Corp.; Eisai Inc., Woodcliff Lake, NJ, USA
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and Eisai Inc., Woodcliff Lake, NJ, USA.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a755995ee3876352750ed96a1592330
https://doi.org/10.1200/jco.2022.40.6_suppl.432
https://doi.org/10.1200/jco.2022.40.6_suppl.432
Publikováno v:
In European Urology Open Science November 2021 33 Supplement 3:S368-S368